Caspase mediated enhanced apoptotic action of cyclophosphamideand resveratrol-treated cf-7 cells

Journal of Pharmacological Sciences

Volumn 109, Issue 4, 2009, Pages 473-485

  Singh, Neetu ^a   Nigam, Manisha ^b   Ranjan, Vishal ^b   Sharma, Ramesh ^b   Balapure, Anil Kumar ^b   Rath, Srikanta Kumar ^b  

^a Developmental Toxicology Research Centre   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Combination chemotherapeutic regimen; Cyclophosphamide; MCF 7; Resveratrol

Indexed keywords

CASPASE; CYCLOPHOSPHAMIDE; FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL KILLING; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; EMBRYO; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MONOTHERAPY; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 66249119019     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08173FP     Document Type: Article

References (44)

1. Shah MA, Schwartz GK. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin Cancer Res. 2001;7: 2168-2181.
2. Moore MJ. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet. 1991;20:194-208.
3. Sladek NE. Metabolism of oxazaphosphorines. Pharmacol Ther. 1988;37:301-355.
4. Chhipa RR, Singh S, Surve SV, Vijayakumar MV, Bhat MK. Doxycycline potentiates antitumor effect of cyclophosphamide in mice. Toxicol Appl Pharmacol. 2005;202:268-277.
5. Fulda S, Debatin KM. Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review. Cancer Detec Prevent. 2006;30:217-223.
6. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticanceres. 2004;24:2783-27840.
7. Chang JC, Wergowske G. Correlation of estrogen receptors and response to chemotherapy of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in advanced breast cancer. Cancer. 1981;48:2503-2506.
8. Srivastava A, Tiwari M, Sinha RA, Balapure AK, Bajpai VK, Sharma R, et al. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving mitochondria-mediated pathway. J Biol Chem. 2006;281:19762-19771.
9. Soto AM, Sonnenschesin C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem. 1985;25:87-94.
10. Perry RR, Kang Y, Greaves B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and estrogen-independent human breast cancer cells. Ann Surg Oncol. 1995;2:238-245.
11. Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 1998;273:9357-9360.
12. Nair VD, Yuen T, Olanow CW, Sealfon SC. Early single cell bifurcation of pro- and anti-apoptotic states during oxidative stress. J Biol Chem. 2004;279:27494-27501.
13. Zhu J, Nozell S, Wang J, Jiang J, Zhou W, Chen X. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene. 2001;20: 4050-4057.
14. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817-825.
15. Friedlander P, Haupt Y, Prives C, Oren M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol. 1996;16:4961-4971.
16. Ludwig RL, Bates S, Vousden KH. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol. 1996;16:4952-4960.
17. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80: 293-299.
18. Thornborrow EC, Manfredi JJ. One mechanism for cell type specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element. J Biol Chem. 1999;274:33747-33756.
19. Nigam M, Ranjan V, Srivastava S, Sharma R, Balapure AK. Centchroman induces G0/G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells. Life Sci. 2008;82:577-590.
20. Rodriguez-Antona C, Donato MT, Boobis A, Edwards RJ, Watts PS, Castell JV, et al. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica. 2002;32:505-520.
21. Chen G, Waxman DJ. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells. Biochem Pharmacol. 1995;49: 1691-1701.
22. Surh YJ, Hurh YJ, Kang JY, Lee E, Kong G, Lee SJ. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 1999;140: 1-10.
23. Bernhard D, Tinhofer I, Tonko M, Hubl H, Ausserlechner MJ, Greil R, et al. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 2000;7:834-842.
24. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM. The antiproliferative activity of resveratrol results in apoptosis in MCF7 but not in MDA-MB-231 human breast cancer cells: cell specific alteration of the cell cycle. Biochem Pharmacol. 2002;64:1375-1386.
25. Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N, Ghidoni R. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J. 2003;17:2339-2341.
26. Ragione FD, Cucciolla V, Borriello A, Pietra VD, Racioppi L, Soldati G, et al. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun. 1998;250:53-58.
27. Park JW, Choi YJ, Jang MA, Lee YS, Jun DY, Suh SI, et al. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett. 2001;163:43-49.
28. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 1998;92:996-1002.
29. Li F, Srinivasan A, Wang Y, Armstrong RC, Tomaselli KJ, Fritz LC. Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-xL has activity independent of cytochrome crelease. J Biol Chem. 1997;272:30299-30305.
30. Ferry-Dumazet H, Garnier O, Mamani-Matsuda M, Vercauteren J, Belloc F, Billiard C, et al. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis. 2002;23:1327-1333.
31. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545-1556.
32. Takeba Y, Kumai T, Matsumoto N, Nakaya S, Tsuzuki Y, Yanagida Y, et al. Irinotecan activates p53 with its active metabolite, resulting in human hepatocellular carcinoma apoptosis. J Pharmacol Sci. 2007;104:232-242.
33. Martinez LA, Yang J, Vazquez ES, Rodriguez-Vargas M del C, Olive M, Hsieh J-T, et al. p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells. Carcinogenesis. 2002;23:1289-1296.
34. Canman CE, Gilmer TM, Coutts SB, Kastan MB. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 1995;9:600-611.
35. Kagawa S, Fujiwara T, Hizuta A, Yasuda T, Zhang WW, Roth JA, et al. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells. Oncogene. 1997;15:1903-1909.
36. Zhuang S, Lynch MC, Kochevar IE. Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells. Exp Cell Res. 1999; 250:203-212.
37. Martelli AM, Cappellini A, Tazzari PL, Billi AM, Tassi C, Ricci F, et al. Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes. Haematologica. 2004;89:471-479.
38. Coelho D, Holl V, Weltin D, Lacornerie T, Magnenet P, Dufour P, et al. Caspase-3-like activity determines the type of cell death following ionizing radiation in MOLT-4 human leukaemia cells. Br J Cancer. 2000;83:642-649.
39. Tiwari M, Kumar A, Sinha RA, Shrivastava A, Balapure AK, Sharma R, et al. Mechanism of 4-HPR induced apoptosis in glioma cells: evidences suggesting role of mitochondrialmediated pathway and endoplasmic reticulum stress. Carcinogenesis. 2006;27:2047-2058.
40. Petak I, Houghton JA. Shared pathways: Death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res. 2001;7:95-106.
41. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007;16:1246-1252.
42. Turner RT, Evans GL, Zhang M, Maran A, Sibonga JD. Is resveratrol an estrogen agonist in growing rats? Endocrinology. 1999;140:50-54.
43. Zhang J, Tian Q, Zhou Shu-F. Clinical pharmacology of cyclophosphamide and ifosfamide. Current Drug Therapy. 2006;1:55-84.
44. Hebbar V, Shen G, Hu R, Kim BR, Chen C, Korytko PJ, et al. Toxicogenomics of resveratrol in rat liver. Life Sci. 2005;76:2299-2314.